m.LearnBecome a PartnerBecome a Partner
m.Stock by Mirae AssetOpen Demat Account
m.Stock by Mirae Asset
LoginOpen Demat Account
m.Stock by Mirae Asset
LoginOpen Demat Account
Tatva Chintan Pharma Chem Ltd logo

Tatva Chintan Pharma Chem Ltd Share Price

Current price unavailable.
As on - | -
ChemicalsSmall Cap
BuySell

Volume Analysis

SPOT Pivot Levels

TypeClassicFibonacci
R1 1,325.531,327.1
R21,356.771,338.43
R31,373.531,356.77
PP1,308.77 1,308.77
S11,325.531,327.1
S21,260.771,279.1
S3 1,229.531,260.77

Ratios

ParticularsDec 2025Sep 2025Jun 2025Mar 2025Dec 2024
ROCE-2.58-0.23-
ROE-1.91-0.05-
EPS6.843.822.190.47-0.5

Peer Comparison

No data available
Scrip NamePriceDaily changeM CapPE Ratio1 Year Return

Corporate Action

April 29, 2026
Format of Initial Disclosure to be made by an entity identified as a Large Corporate.

Sr. No. Particulars Details
1Name of CompanyTatva Chintan Pharma Chem Ltd
2CIN NO.L24232GJ1996PLC029894
3 Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr) 6.04
4Highest Credit Rating during the previous FY BBB+
4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)CRISIL LTD.
5Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the frameworkBSE


We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No



Name of the Company Secretary: Ishwar Nayi
Designation: Company Secretary and Compliance Officer
EmailId: cs@tatvachintan.com
Name of the Chief Financial Officer: Ajesh Pillai
Designation: Chief Financial Officer
EmailId: ajesh@tatvachintan.com

Date: 29/04/2026

Note: In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.
April 29, 2026
Format of the Annual Disclosure to be made by an entity identified as a Large Corporate.

Sr. No. Particulars Details
1 Name of Company Tatva Chintan Pharma Chem Ltd
2 CIN NO. L24232GJ1996PLC029894
3 Report filed for FY 2025-2026
Details of the Current block (all figures in Rs crore):
4 2 - year block period (Specify financial years)* FY 2025-26 and FY 2026-27
5 Incremental borrowing done in FY (T)(a) 0.00
6 Mandatory borrowing to be done through debt securities in FY (T) (b) = (25% of a) 0.00
7 Actual borrowing done through debt securities in FY (T)(c) 0.00
8 Shortfall in the borrowing through debt securities if any for FY (T - 1) carried forward to FY (T) (d) 0
8Quantum of (d) which has been met from (c)(e)* 0
9 Shortfall if any in the mandatory borrowing through debt securities for FY (T) { after adjusting for any shortfall in borrowing for FY(T - 1) which was carried forward to FY(T)}(f) = (b) - [(c) - (e)]{ If the calculated value is zero or negative write nil}* 0


Details of penalty to be paid if any in respect to previous block (all figures in Rs crore):
2 - year Block period (Specify financial years)FY 2024-25 and FY 2025-26
Amount of fine to be paid for the block if applicable Fine = 0.2% of {(d) - (e)}#0.00



Name of the Company Secretary :-Ishwar Nayi
Designation :-Company Secretary and Compliance Officer
Name of the Chief Financial Officer :- Ajesh Pillai
Designation : -Chief Financial Officer

Date: 29/04/2026

About Tatva Chintan Pharma Chem Ltd

Equity img
Tatva Chintan Pharma Chem Limited was formerly incorporated as 'Tatva Chintan Pharma Chem Private Limited' on 12 June 1996. The status of the Company converted from Private Limited into a Public Limited Company from 27 January 2021 and the name of Company changed from 'Tatva Chintan Pharma Chem Private Limited' to 'Tatva Chintan Pharma Chem Limited'. The Company is promoted by Mr. Chintan Nitin Ku...
ISIN :INE0GK401011

Registered Office

No 502/17 GIDC Estate,Ankleshwar

Contact number

+ +91-75730-46951/46952

Email

Registrars

MUFG Intime India Pvt Ltd
C-101 247 Park L B S Marg Vikhroli West Mumbai-400083

Contact number

+ 91-22-49186000

Email

Management

Chintan Nitinkumar Shah (Chairman)

Open IPO’s

View All

FAQs

The share price of Tatva Chintan Pharma Chem Ltd on the BSE is - as on -

Note : Securities shown above are only for illustrative purposes and not recommendatory in nature. The data represents best/cumulative figures till date.